Canadian Halal Investor.

NASDAQ Shariah screener · October 2026

Is Intuitive Surgical, Inc. (ISRG) Halal?

PASS

Intuitive Surgical, Inc. · NASDAQ: ISRG · Healthcare

The short answer

Yes — Intuitive Surgical (ISRG) passes this Shariah stock screen. The Sunnyvale, California company makes robotic-assisted surgical technology (da Vinci surgical systems and the Ion endoluminal lung-biopsy system) plus instruments, accessories and services — all medical-device activity, with no haram business segments disclosed in its FY2025 10-K. The financial ratios pass comfortably: ISRG carries no debt at all on its FY2025 10-K or Q2 2026 10-Q balance sheets (0.00% of its ~$141.75B market cap — 353,278,038 shares × $401.24, October 1, 2026), below the ~33% ceiling, and its 'interest and other income, net' of $365.9M is 3.64% of FY2025 revenue ($10,064.7M), below the 5% ceiling. Musaffa classifies ISRG as HALAL (AAOIFI, as of October 2026). This is a factual screen, not a religious ruling — consult a qualified scholar for personal rulings.

Gate 1 — Business activity: PASS

Intuitive Surgical, Inc. (NASDAQ: ISRG), founded in 1995 and headquartered in Sunnyvale, California, develops robotic-assisted, minimally invasive care technology: da Vinci surgical systems (first launched 1999; current models include the fifth-generation da Vinci 5, da Vinci X, da Vinci Xi and da Vinci SP, used across general surgery, urologic, gynecologic, cardiothoracic and head-and-neck procedures) and the Ion endoluminal system for minimally invasive lung biopsies. Its business model is systems placement plus recurring revenue: instruments and accessories (limited-life items replaced as procedures are performed), and services (five-year service contracts, typically $55,000–$70,000 per year). FY2025 revenue of $10,064.7M = instruments and accessories $6,018.9M + systems $2,473.7M + service $1,572.1M. Business-screen implication (factual): all activity is medical devices; the 10-K discloses no alcohol, gambling, conventional finance, pork, weapons or tobacco revenue — no haram segments. Gate 1 passes. Facts only.

Gate 2 — Debt and cash: PASS

Per ISRG's Q2 2026 10-Q (filed July 21, 2026; SEC CIK 1035267, accession 0001035267-26-000058), the balance sheet carries no debt lines at all — no short-term debt, no long-term debt, no borrowings (total liabilities of $2,578.9M are operating items: accounts payable, accrued compensation, deferred revenue). Total debt is effectively $0. Against a market cap of about $141.75B (353,278,038 shares outstanding per the 10-Q cover × $401.24, October 1, 2026, Finnhub), debt ÷ market cap is 0.00% — below the ~33% ceiling. Cash, cash equivalents and investments of $8,625.5M (cash $2,760.4M + short-term investments $2,455.8M + long-term investments $3,409.3M) are about 6.09% of market cap. The debt gate passes. Facts only.

Gate 3 — Non-compliant income: PASS

ISRG's FY2025 10-K (filed February 3, 2026; accession 0001035267-26-000010) reports 'Interest and other income, net' of $365.9M against FY2025 total revenue of $10,064.7M — about 3.64% of revenue, below the 5% non-compliant income ceiling. The interest-income component is not disclosed separately in the filings; MD&A states the increase was driven by higher interest income earned on cash and investment balances, and Zoya's own ISRG page cites this same $365.9M figure and computes the same 3.64% ratio. This is the broadest verifiable interest/investment income line from primary filings. The income gate passes. Facts only.

Key figures used

Frequently asked questions

What does Intuitive Surgical do?

Intuitive Surgical, Inc., founded in 1995 and headquartered in Sunnyvale, California, develops robotic-assisted minimally invasive care technology. Its core products are the da Vinci surgical systems (launched 1999; current models include the fifth-generation da Vinci 5 plus da Vinci X, Xi and SP) used across general surgery, urologic, gynecologic, cardiothoracic and head-and-neck procedures, and the Ion endoluminal system for minimally invasive lung biopsies. It also sells instruments and accessories (limited-life items replaced as procedures are performed) and services (five-year service contracts, typically $55,000–$70,000 per year). FY2025 revenue was $10,064.7M: instruments and accessories $6,018.9M, systems $2,473.7M, service $1,572.1M — all medical-device activity with no haram segments disclosed.

Why does ISRG pass this Shariah stock screen?

ISRG passes this Shariah stock screen at all three gates. Gate 1 (business activities): robotic-assisted surgical systems, instruments and services are medical-device activity — no alcohol, gambling, conventional finance, pork, weapons or tobacco revenue. Gate 2 (debt): the FY2025 10-K and Q2 2026 10-Q balance sheets carry no short-term or long-term debt at all, so debt ÷ market cap is 0.00% against the ~33% ceiling. Gate 3 (interest income): FY2025 interest and other income, net of $365.9M is 3.64% of $10,064.7M revenue, under the 5% ceiling. This is a factual screen, not a religious ruling — consult a qualified scholar for personal rulings.

What is ISRG's interest-bearing debt ratio?

Per ISRG's Q2 2026 10-Q (filed July 21, 2026; SEC CIK 1035267, accession 0001035267-26-000058), the balance sheet contains no debt lines — no short-term debt, no long-term debt, no borrowings. Total debt is effectively $0. Against a market cap of about $141.75B (353,278,038 shares outstanding per the 10-Q cover × $401.24, October 1, 2026, Finnhub), debt ÷ market cap is 0.00% — below the ~33% ceiling. Cash, cash equivalents and investments of $8,625.5M at June 30, 2026 are about 6.09% of market cap. The debt gate passes.

What is ISRG's non-compliant income ratio?

ISRG's FY2025 10-K (filed February 3, 2026; accession 0001035267-26-000010) reports 'Interest and other income, net' of $365.9M against FY2025 total revenue of $10,064.7M — about 3.64% of revenue, below the 5% non-compliant income ceiling. The interest-income component is not disclosed separately; MD&A attributes the increase to higher interest income earned on cash and investment balances. This is the broadest verifiable interest/investment income line from the filings, and Zoya's own ISRG page cites the same $365.9M figure and computes the same 3.64%. The income gate passes.

Do Zoya, Musaffa, or ShariaPortfolio cover ISRG?

Zoya covers ISRG (zoya.finance/stocks/isrg) and cites FY2025 revenue of $10,064.7M with interest income of $365.9M (3.64%), but its public page renders contradictory auto-generated template text (simultaneously calling ISRG Shariah-compliant/halal and not), so no clean Zoya rating is retrievable — reported as inconclusive. Musaffa covers ISRG and classifies it HALAL (AAOIFI methodology, as of October 2026; also listed in Musaffa Academy's Nasdaq 100 halal-stock list). ShariaPortfolio: no ISRG entry found. All honestly reported as found, not invented. This page applies the screen directly from ISRG's own filings.

Sources

Screened 2026-10-01 from published company figures and market data. Figures change; this page is educational, not financial advice and not a religious ruling.

Screened with our two-gate Shariah screening methodology (business-activity gate, then AAOIFI-style financial ratios).